CLINICAL_TRIALS trial_result · 2020-08-24

Clinical Trial Update: Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study [Phase 4]

A Phase 4 validation study comparing prasugrel and ticagrelor in patients with CYP2C19 loss-of-function variants, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Florida | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2020-08-24